Hypoxic pulmonary vasoconstriction (HPV) is a physiological response to a decrease in airway O(2) tension, but the underlying mechanism is incompletely understood. We studied the contribution of
glucose-6-phosphate dehydrogenase (Glc-6-PD), an important regulator of
NADPH redox and production of
reactive oxygen species, to the development of HPV. We found that
hypoxia (95% N(2), 5% CO(2)) increased contraction of bovine pulmonary artery (PA) precontracted with KCl or
serotonin. Depletion of extracellular
glucose reduced
NADPH,
NADH, and HPV, substantiating the idea that
glucose metabolism and Glc-6-PD play roles in the response of PA to
hypoxia. Our data also show that inhibition of glycolysis and mitochondrial respiration (indicated by an increase in
NAD(+) and decrease in the
ATP-to-
ADP ratio) by
hypoxia, or by inhibitors of
pyruvate dehydrogenase or electron transport chain complexes I or III, increased generation of
reactive oxygen species, which in turn activated Glc-6-PD. Inhibition of Glc-6-PD decreased Ca(2+) sensitivity to the myofilaments and diminished Ca(2+)-independent and -dependent
myosin light chain phosphorylation otherwise increased by
hypoxia. Silencing Glc-6-PD expression in PA using a targeted
small interfering RNA abolished HPV and decreased extracellular Ca(2+)-dependent PA contraction increased by
hypoxia. Similarly, Glc-6-PD expression and activity were significantly reduced in lungs from Glc-6-PD(mut(-/-)) mice, and there was a corresponding reduction in HPV. Finally, regression analysis relating Glc-6-PD activity and the
NADPH-to-
NADP(+) ratio to the HPV response clearly indicated a positive linear relationship between Glc-6-PD activity and HPV. Based on these findings, we propose that Glc-6-PD and
NADPH redox are crucially involved in the mechanism of HPV and, in turn, may play a key role in increasing pulmonary arterial pressure, which is involved in the development of
pulmonary hypertension.